Score Breakdown
Offering Ability
52
Cash Runway
10
Float Risk—
Warrant Exposure
40
Convertible Debt
40
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for RNAM.
Market Data
Market CapN/A
Shares Outstanding155.15M
FloatN/A
Cash$644.37M
DebtN/A
Short InterestN/A
Institutional Holdings
Institutional data not yet available.
Short Interest
No current FINRA short-interest record is available for this ticker.
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2021-12-31
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual RNAM Dilution Snapshot
Avidity Biosciences, Inc. (RNAM) has a DilutionScore of 33/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for RNAM: xbrl on 2021-12-31.
- Score coverage note: Float Risk is excluded because public-float data is unavailable.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:
📖 Dilution Education
Score Coverage Note
- Float Risk is excluded because public-float data is unavailable.